Randomized phase II study evaluating palbociclib in addition to letrozole as neoadjuvant therapy in estrogen receptor–positive early breast cancer: PALLET trial
Journal of Clinical Oncology | Jan 21, 2019
Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
Osteoporosis International | Jan 21, 2019
All-cause mortality in patients on sulphonylurea monotherapy compared to metformin monotherapy in a nation-wide cohort
Diabetes Research and Clinical Practice | Jan 21, 2019
Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT Extension I Trials
Journal of Bone and Mineral Research | Jan 20, 2019
Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients
Journal of Translational Medicine | Jan 20, 2019